Immune Therapy and β-Cell Death in Type 1 Diabetes
Article Information
vol. 62 no. 5 1676-1680
PubMed
Published By
Print ISSN
Online ISSN
History
- Received September 2, 2012
- Accepted November 23, 2012
- Published in print April 23, 2013.
- Published online ahead of print February 19, 2013.
Article Versions
- Previous version (February 19, 2013 - 13:08).
- Previous version (February 27, 2013 - 11:30).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
Author Information
- Jasmin Lebastchi1,
- Songyan Deng1,
- Amir H. Lebastchi1,
- Isabel Beshar1,
- Stephen Gitelman2,
- Steven Willi3,
- Peter Gottlieb4,
- Eitan M. Akirav5,
- Jeffrey A. Bluestone6 and
- Kevan C. Herold1⇑
- 1Departments of Immunobiology and Internal Medicine and Surgery, Yale University School of Medicine, New Haven, Connecticut
- 2Department of Pediatrics, University of California, San Francisco, San Francisco, California
- 3Department of Endocrinology, Children’s Hospital of Philadelphia, and Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
- 4Department of Internal Medicine, University of Colorado at Denver, Aurora, Colorado
- 5Diabetes and Obesity Center, Winthrop University Hospital, Mineola, New York
- 6Department of Internal Medicine, University of California, San Francisco, San Francisco, California
- Corresponding author: Kevan C. Herold, kevan.herold{at}yale.edu.
Statistics from Altmetric.com
Article usage
In this Issue
May 2013, 62(5)
